Newton, MA, United States of America

Lana Dinic

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Lana Dinic: Innovator in Biomedical Science**

Introduction

Lana Dinic, a talented inventor based in Newton, MA, has made significant contributions to the field of biomedical science. With a focus on immunology, her work has led to the development of innovative solutions aimed at addressing certain medical challenges.

Latest Patents

Lana Dinic holds one patent titled "Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)." This groundbreaking patent discloses various embodiments of polypeptides, such as antibodies and their antigen-binding fragments that bind specifically to thymic stromal lymphopoietin. The patent details fusion proteins comprising the polypeptides, polynucleotides encoding them, and the methods for treating diseases or conditions associated with TSLP.

Career Highlights

Lana Dinic currently works with Flagship Pioneering Innovations Vi, LLC, where she contributes her expertise in the development of biopharmaceuticals. Her innovative mindset and dedication to research have positioned her as a prominent figure in her field.

Collaborations

Throughout her career, Lana has collaborated with notable colleagues such as Antonios O Aliprantis and Zachary Kohl Costello. These collaborations have helped enhance the depth and impact of her research, fostering advancements in immunotherapy and other related areas.

Conclusion

Lana Dinic is an inspiring inventor whose work continues to push the boundaries of biomedical innovation. Her contributions, especially in the realm of TSLP-targeting molecules, highlight the importance of research in tackling complex health issues. With her ongoing efforts and collaborations, she is set to pave the way for further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…